Emraclidine
id:
emraclidine-273-8249890
title:
Emraclidine
text:
Emraclidine is an investigational antipsychotic for the treatment of both schizophrenia and Alzheimer's disease psychosis developed by Cerevel Therapeutics. As of February 2023, it is in phase II of clinical trial. Emraclidine is a positive allosteric modulator that selectively targets the muscarinic acetylcholine receptor M4 subtype. The M4 receptor subtype is expressed in the striatum of the brain, which plays a key role in regulating acetylcholine and dopamine levels. An imbalance of these ne
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Emraclidine
date created:
date modified:
2024-03-22T10:28:40Z
main entity:
{"identifier":"Q116786342","url":"https://www.wikidata.org/entity/Q116786342"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/0a/Emraclidine.svg","width":890,"height":300}
fields total:
13
integrity:
15